| Date Filed | Type | Description |
| 10/03/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 457 shares
@ $20.26, valued at
$9.3k
|
|
| 08/22/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,028 shares
@ $19.46, valued at
$20k
|
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 457 shares
@ $20.46, valued at
$9.4k
|
|
| 05/23/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,027 shares
@ $13.03, valued at
$13.4k
Granted 23,355 options to buy
@ $67.85, valued at
$1.6M
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 2,176 shares
@ $27.03, valued at
$58.8k
Paid exercise price by delivering 457 shares
@ $15.08, valued at
$6.9k
|
|
| 02/22/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,027 shares
@ $22.52, valued at
$23.1k
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 337 shares
@ $28.74, valued at
$9.7k
|
|
| 01/05/2023 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 283 shares
@ $23.81, valued at
$6.7k
Paid exercise price by delivering 220 shares
@ $23.81, valued at
$5.2k
|
|
| 12/21/2022 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Granted 35,484 shares
@ $0 |
|
| 11/22/2022 |
4
| Finn Patrick John (President and COO) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,027 shares
@ $24.81, valued at
$25.5k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 257 shares
@ $35.24, valued at
$9.1k
Paid exercise price by delivering 200 shares
@ $35.24, valued at
$7k
|
|
| 08/23/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,027 shares
@ $42.81, valued at
$44k
|
|
| 07/26/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 305 shares
@ $43.52, valued at
$13.3k
|
|
| 07/06/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 457 shares
@ $37.08, valued at
$16.9k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 305 shares
@ $34.21, valued at
$10.4k
|
|
| 04/05/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 457 shares
@ $52.91, valued at
$24.2k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 336 shares
@ $55.87, valued at
$18.8k
|
|
| 01/20/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 220 shares
@ $77.39, valued at
$17k
|
|
| 01/05/2022 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 283 shares
@ $77.39, valued at
$21.9k
|
|
| 12/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 1,027 shares
@ $110.62, valued at
$113.6k
|
|
| 11/04/2021 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Sold 1,758 shares
@ $127.23, valued at
$223.7k
Exercised 1,517 options to buy
@ $26.66, valued at
$40.4k
Exercised 241 options to buy
@ $23.33, valued at
$5.6k
|
|
| 10/26/2021 |
4
| Finn Patrick John (Chief Commercial Officer) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Paid exercise price by delivering 305 shares
@ $117.41, valued at
$35.8k
|
|
|